Cargando…

Interactions between Diabetes and the Heart

Detalles Bibliográficos
Autores principales:	Skoularigis, John, Melidonis, Andreas, Westermann, Dirk, Georgiopoulou, Vasiliki V., Karagiannis, Georgios, Giamouzis, Gregory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745821/ https://www.ncbi.nlm.nih.gov/pubmed/26904691 http://dx.doi.org/10.1155/2016/8032517

Ejemplares similares

Heart Failure 2013
por: Giamouzis, Gregory, et al.
Publicado: (2013)

Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus
por: Xanthopoulos, Andrew, et al.
Publicado: (2017)

Heart Failure
por: Giamouzis, Gregory, et al.
Publicado: (2011)

Editorial: Novel and emerging therapies in heart failure
por: Giamouzis, Grigorios, et al.
Publicado: (2023)

Current Status of Mechanical Circulatory Support: A Systematic Review
por: Spiliopoulos, Kyriakos, et al.
Publicado: (2012)

Cognitive Impairment in Heart Failure
por: Dardiotis, Efthimios, et al.
Publicado: (2012)

Heart failure with preserved ejection fraction: A distinct heart failure phenotype?
por: Triposkiadis, Filippos, et al.
Publicado: (2022)

Heart failure with reduced, mildly reduced, or preserved left ventricular ejection fraction: Has reasoning been lost?
por: Xanthopoulos, Andrew, et al.
Publicado: (2022)

Heart Failure 2012
por: Giamouzis, Gregory, et al.
Publicado: (2012)

A Holistic View of Advanced Heart Failure
por: Triposkiadis, Filippos, et al.
Publicado: (2022)

Glucose lowering does not necessarily reduce cardiovascular risk in type 2 diabetes
por: Bourazana, Angeliki, et al.
Publicado: (2022)

Growing Evidence Linking Microvascular Dysfunction With Heart Failure With Preserved Ejection Fraction
por: Giamouzis, Gregory, et al.
Publicado: (2016)

Relative contribution of risk factors/co‐morbidities to heart failure pathogenesis: interaction with ejection fraction
por: Giamouzis, Grigorios, et al.
Publicado: (2020)

Red Blood Cell Distribution Width in Heart Failure: Pathophysiology, Prognostic Role, Controversies and Dilemmas
por: Xanthopoulos, Andrew, et al.
Publicado: (2022)

Lipomatous Hypertrophy of the Interatrial Septum: A Case Report and Review of the Literature
por: Xanthopoulos, Andrew, et al.
Publicado: (2017)

The effect of SGLT-2i administration on red blood cell distribution width in patients with heart failure and type 2 diabetes mellitus: A randomized study
por: Katsiadas, Nikolaos, et al.
Publicado: (2022)

Efficacy, efficiency and safety of a cardiac telerehabilitation programme using wearable sensors in patients with coronary heart disease: the TELEWEAR-CR study protocol
por: Antoniou, Varsamo, et al.
Publicado: (2022)

COVID-19 and the heart
por: Xanthopoulos, Andrew, et al.
Publicado: (2022)

Telemonitoring in Chronic Heart Failure: A Systematic Review
por: Giamouzis, Gregory, et al.
Publicado: (2012)

The Interventricular Septum: Structure, Function, Dysfunction, and Diseases
por: Triposkiadis, Filippos, et al.
Publicado: (2022)

Larissa Heart Failure Risk Score and Mode of Death in Acute Heart Failure: Insights from REALITY-AHF
por: Xanthopoulos, Andrew, et al.
Publicado: (2023)

Oxidative Stress in the Critically Ill Patients: Pathophysiology and Potential Interventions
por: Makris, Demosthenes, et al.
Publicado: (2018)

The Prognostic Role of Spot Urinary Sodium and Chloride in a Cohort of Hospitalized Advanced Heart Failure Patients: A Pilot Study
por: Xanthopoulos, Andrew, et al.
Publicado: (2023)

Echocardiographic Assessment of Pulmonary Artery Systolic Pressure and Outcomes in Ambulatory Heart Failure Patients
por: Kalogeropoulos, Andreas P., et al.
Publicado: (2014)

Interaction Between Heart Failure and Atrial Fibrillation
por: Kim, Yun Gi
Publicado: (2022)

Diabetes Mellitus and Heart Failure
por: Triposkiadis, Filippos, et al.
Publicado: (2021)

Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure
por: Xanthopoulos, Andrew, et al.
Publicado: (2023)

ACE2, the Counter-Regulatory Renin–Angiotensin System Axis and COVID-19 Severity
por: Triposkiadis, Filippos, et al.
Publicado: (2021)

Type 2 diabetes and quality of life
por: Trikkalinou, Aikaterini, et al.
Publicado: (2017)

The Neurohormonal Overactivity Syndrome in Heart Failure
por: Xanthopoulos, Andrew, et al.
Publicado: (2023)

Circulating microRNAs as biomarkers for diabetic neuropathy: A novel approach
por: Xourgia, Eleni, et al.
Publicado: (2018)

Aspirin in primary prevention of cardiovascular disease in diabetes
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2021)

Mitral stenosis and atrial fibrillation
por: Westermann, Dirk, et al.
Publicado: (2020)

Post-Implant Phosphodiesterase-5 Inhibitors in Patients with Left Ventricular Assist Device: A Systematic Review and Meta-Analysis
por: Xanthopoulos, Andrew, et al.
Publicado: (2022)

Diabetes and dementia – the two faces of Janus
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2020)

Depression in Patients with Cardiovascular Disease
por: Mastrogiannis, Dimos, et al.
Publicado: (2012)

Splenic infarcts as a rare manifestation of parvovirus B19 infection
por: Kranidiotis, Georgios, et al.
Publicado: (2016)

Supercritical CO(2) Extraction of High-Added Value Compounds from Chlorella vulgaris: Experimental Design, Modelling and Optimization
por: Georgiopoulou, Ioulia, et al.
Publicado: (2022)

Recent Advances in Supercritical CO(2) Extraction of Pigments, Lipids and Bioactive Compounds from Microalgae
por: Tzima, Soultana, et al.
Publicado: (2023)

Red blood cell distribution width in elderly hospitalized patients with cardiovascular disease
por: Xanthopoulos, Andrew, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7e4jibsp8n94i5084mcbfgj6fn